Our Issue Panel about the Mutual Learnings on Health Policy Among CEE Countries was accepted to be held at #isporeurope2024 meeting in Barcelona in November! 🎉 🔥 With the moderator Malwina Hołownia-Voloskova, PhD and panelists Gergo Meresz, Oresta Piniazhko and Eva Turk session promises to be an engaging and insightful discussion on the shared experiences and collaborative efforts in health policy across Central and Eastern European countries. Looking forward to sharing our views on the topic!
Arcana Institute, a Certara Company
Produkcja wyrobów farmaceutycznych
Krakow, Malopolska 612 obserwujących
www.inar.pl
Informacje
Evolving marketplace dynamics, cuts in healthcare systems and governments, and the growing cost of innovation pose major challenges to demonstrating and delivering value effectively. Powered by analytics and modeling across the entire life cycle, our commercial, HEOR, and market access teams help you assess and clearly demonstrate value. We combine unmatched technical capabilities and advanced analytic methods with our deep relationships in the payer and health technology assessment (HTA) community to inform key decisions and maximize your product’s impact.
- Witryna
-
https://inar.pl/en/homepage/
Link zewnętrzny organizacji Arcana Institute, a Certara Company
- Branża
- Produkcja wyrobów farmaceutycznych
- Wielkość firmy
- 51-200 pracowników
- Siedziba główna
- Krakow, Malopolska
- Rodzaj
- Spółka prywatna
- Data założenia
- 2002
- Specjalizacje
- Clinical Analysis, Pharmacoeconomic, Market Access, full reimbursement dossiers, health technology assessment, Pricing, pharmacovigilance, Healthcare Management, EBM, Health Outcomes, Health Economics, Clinical Trials, Pharmaceutical Industry i Pharmaceutical Sales
Lokalizacje
-
Główna
17 Kuklinskiego Str.
Krakow, Malopolska 30-720, PL
Pracownicy Arcana Institute, a Certara Company
Aktualizacje
-
Arcana Institute, a Certara Company ponownie to opublikował(a)
Presenting the critical issue of Transferability of Economic Models within Health Technology Assessment in Central and Eastern Europe co-authored by Grzegorz Obrzut and Jacek Walczak Walczak at HTAi in Seville, Spain on the behalf of Arcana Institute, a Certara Company 👍
-
Arcana Institute, a Certara Company ponownie to opublikował(a)
Presenting the critical issue of Transferability of Economic Models within Health Technology Assessment in Central and Eastern Europe co-authored by Grzegorz Obrzut and Jacek Walczak Walczak at HTAi in Seville, Spain on the behalf of Arcana Institute, a Certara Company 👍
-
Podsumowanie naszego X Krakowskiego Sympozjum HTA już dostępne na stronie: https://lnkd.in/dEzfxbUU
-
🚀 Exciting Highlights from the 10th Jubilee HTA Symposium in Cracow! 🚀 On May 20-21, 2024, we celebrated the 10th Jubilee HTA Symposium in Cracow with over 100 enthusiastic attendees, including representatives from the Ministry of Health, the Polish HTA Agency, hospitals, academia, pharmaceutical and medical device companies, and consulting firms. This milestone event featured seven insightful sessions addressing critical topics in health technology assessment (HTA): 1. Amendments to the Reimbursement Act – Where Are We After 6 Months? 2. Joint Clinical Assessment & Joint Scientific Consultation – A Challenge or a Benefit for Central and Eastern European Countries? 3. Reimbursement of Medical Devices in Poland – Are We Facing a Revolution? 4. Real-World Data – Accelerator of the Registration and Reimbursement Process in the EU 5. An Alternative Approach to QALYs – Reimbursement Support for Orphan Drugs 6. A New Era in the Treatment of Obesity - A Disease of Civilization in Poland and Around the World 7. AI Use in Health Technologies The symposium provided a dynamic platform for stakeholders to engage in productive discussions, share innovative ideas, and explore collaborative opportunities. The sessions delved into the latest amendments in reimbursement policies, the evolving landscape of HTA in CEE countries, and the transformative potential of real-world data and AI in healthcare. We extend our thanks to all participants, speakers, and organizers for making this event a resounding success. Let's continue to drive progress and innovation in health technology assessment together! #HTA #HealthcareInnovation #HealthPolicy #Reimbursement #AIinHealthcare #ObesityTreatment #RealWorldData #MedicalDevices #CEEHealth #Pharma #Consulting #Academia #HealthTech Thank you to all speakers: Jacek Walczak, Marcin Czech, Mateusz Oczkowski, Rafał Niżankowski, Michał Byliniak, Bartłomiej Sasin, Dominika Chrabańska, Gergo Meresz, Piotr Szymański, Timothy Mann, Jacek Siwiec, Agnieszka Wisniewska, Tomasz Koeber, Oleg Borisenko, MD, PhD, Agnieszka Pietraszewska-Macheta, Maciej Banach, Kacper Rucinski, Marta Martinez Rodriguez, Nadia PETIOT, Professor Khalid Khan, Anna Kostera-Pruszczyk, Sylwia Łukomska, Maciej Niewada, Edward Franek, Anna Fijałkowska, Magdalena Gierlak, Katarzyna Lasota, Noemi Hummel, Dmitry Gultyaev, Artur Nowak, Michal Chodorek, Michał Harańczyk M.D.
-
Dziękujemy za rewelacyjne tłumaczenie!
🎤🎧Tłumaczania konferencyjne i naukowe PL-EN | 🌎Koordynatorka medyczna ds. pacjentów zagranicznych | 😷Specjalistka psychodietetyki
🔊Za nami 10. Jubileuszowe Krakowskie Sympozjum HTA, podczas którego miałam przyjemność tłumaczyć symultanicznie bardzo ważne tematy dotyczące polityki lekowej, a mianowicie: ✔️Nowelizacja ustawy refundacyjnej.💊 ✔️Joint Clinical Assessment & Joint Scientific Consultation.💻 ✔️Refundacja wyrobów medycznych w Polsce.💉 ✔️Nowa era leczenia otyłości – choroby cywilizacyjnej w Polsce i na świecie.🩺 ✔️Real-World Data – akcelerator procesu rejestracji i refundacji w UE.📀 ✔️Wykorzystanie AI w technologiach medycznych.⌨️ ✔️Alternatywne podejście do QALY – wsparcie refundacji dla leków sierocych.🧬 Dyskusje bardzo istotne dla przyszłości nas wszystkich, czyli pacjentów, którzy potrzebują wsparcia ze strony różnych aktorów branży medycznej, rządowej i samorządowej. 🆘 Trzymam kciuki za pozytywne wyniki nowelizacji i dalszy rozwój technologii medycznych. ✊ Dziękuję za zaproszenie do współpracy Biuro Tłumaczeń Language Link. 🙂 Iwona Gandor - dziękuję za sprawną i miłą współpracę w kabinie. 🎤🎧 #PolitykaLekowa #Refundacja #Otyłość #NFZ #AI #TłumaczUstny #Medycyna #Prawo #MedicalInterpreting #law #Reimbursement #Certara
-
Thanks for being with us!
🚀Excited to share my experience from the 10th HTA Symposium in Krakow! 🌟 This event brought together leading experts, policymakers, and industry professionals to discuss the latest advancements and challenges in HTA. Here are topics discussed: Legislative Updates: Insights into the latest amendment of the reimbursement law and its impact on the healthcare system. Joint Clinical Assessment & Joint Scientific Consultation — a challenge or a benefit for the countries of Central and Eastern Europe? Medical Device Reimbursement in Poland. Real-World Data: Exploring how real-world data accelerates registration and reimbursement processes across the EU. Alternative Approaches to QALY: Supportive discussions on reimbursement for orphan drugs through alternative approaches to QALY. New Era in Obesity Treatment: Addressing obesity as a modern epidemic both in Poland and globally, and the latest advancements in treatment. AI in Medical Technologies. A huge thank you to the organizers Certara, Malwina Hołownia-Voloskova, PhD for putting together such a comprehensive and impactful event. The knowledge and connections gained here will undoubtedly contribute to advancing HTA practices worldwide. Looking forward to continuing the conversations and collaborations sparked during this symposium! #HTA #HealthTechnology #Symposium #HealthcareInnovation #Networking #Krakow #ProfessionalDevelopment
-
Arcana Institute, a Certara Company ponownie to opublikował(a)
Our X HTA Cracow Symposium was opened by Jacek Walczak! Now we are listening to a great opening session about the reimbursement act in Poland with Rafał Niżankowski, Mateusz Oczkowski, Michał Byliniak, Marcin Czech, Bartłomiej Sasin and Dominika Chrabańska - stay tuned👍
REGISTRATION IS OPEN! We are thrilled to invite You to the 10th Jubilee Krakow HTA Symposium, taking place on May 20-21, 2024, at the Manggha Museum of Japanese Art and Technology in Krakow. With a decade of excellence behind us, this year's Symposium promises to be an enlightening and engaging event, designed to delve into the current trends and challenges shaping the landscape of reimbursement. Our esteemed speakers will navigate a diverse array of topics, including: - Joint Clinical Assessment and Joint Scientific Consultation - challenges or advantages for Central and Eastern European countries? - Reimbursement of medical devices in Poland - is a revolution ahead? - Real-world data as an accelerator of the process of registration and reimbursement in the EU - Use of artificial intelligence in health technology assessment - New era of treatment of obesity - civilization disease in Poland and worldwide - Assessing Value and QALY Alternatives as rare diseases support We are honored to have representatives from esteemed healthcare institutions joining us for insightful discussions on drug reimbursement and the advancement of Evidence- Based Medicine against the backdrop of the current geopolitical scenario. It's worth noting that, akin to last year, the Symposium is not only an intellectual gathering but also a charitable endeavor. We warmly invite you to support the Symposium to seize the opportunity to network, gain valuable insights, and contribute to the advancement of healthcare. Looking forward to your esteemed presence at the 10th Jubilee Krakow HTA Symposium! Link to register - below: https://lnkd.in/dCcQ82DA
Ta treść nie jest tutaj dostępna
Uzyskaj dostęp do tej i innych treści w aplikacji LinkedIn
-
Current program of our X HTA Cracow Symposium available: Register now here: https://lnkd.in/dCcQ82DA